Poolbeg Pharma eyes ‘value-creating milestones’ with cancer therapy data set to emerge

09/29/25

Poolbeg Pharma eyes ‘value-creating milestones’ with cancer therapy data set to emerge

...

Poolbeg Pharma treatment gets FDA backing

05/27/25

Poolbeg Pharma treatment gets FDA backing

...

Poolbeg Pharma expands treatment into new markets

04/30/24

Poolbeg Pharma expands treatment into new markets

...

Poolbeg identifies strategic drug targets for treatment of RSV

12/20/23

Poolbeg identifies strategic drug targets for treatment of RSV

...

Poolbeg Pharma gets go-ahead for Japanese patent of ‘blockbuster’ influenza treatment

09/20/23

Poolbeg Pharma gets go-ahead for Japanese patent of ‘blockbuster’ influenza treatment

...

Poolbeg Pharma uses AI to identify potential drug targets for flu treatment

06/29/23

Poolbeg Pharma uses AI to identify potential drug targets for flu treatment

...

Poolbeg Pharma granted US patent related to influenza drug

03/08/23

Poolbeg Pharma granted US patent related to influenza drug

...

Poolbeg Pharma releases positive data from influenza trial

03/02/23

Poolbeg Pharma releases positive data from influenza trial

...

Poolbeg Pharma sees positive test results for new flu drug

01/09/23

Poolbeg Pharma sees positive test results for new flu drug

...

Poolbeg Pharma sees AI breakthrough in RSV drug discovery

11/08/22

Poolbeg Pharma sees AI breakthrough in RSV drug discovery

...

Poolbeg Pharma
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.